Fulgent Genetics, Inc. (FLGT): Price and Financial Metrics

Fulgent Genetics, Inc. (FLGT): $21.38

0.53 (+2.54%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

FLGT Price/Volume Stats

Current price $21.38 52-week high $44.09
Prev. close $20.85 52-week low $19.88
Day low $20.88 Volume 41,628
Day high $21.41 Avg. volume 189,167
50-day MA $21.28 Dividend yield N/A
200-day MA $25.67 Market Cap 639.78M

FLGT Stock Price Chart Interactive Chart >


Fulgent Genetics, Inc. (FLGT) Company Bio


Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is based in Temple City, California.


FLGT Latest News Stream


Event/Time News Detail
Loading, please wait...

FLGT Latest Social Stream


Loading social stream, please wait...

View Full FLGT Social Stream

Latest FLGT News From Around the Web

Below are the latest news stories about FULGENT GENETICS INC that investors may wish to consider to help them evaluate FLGT as an investment opportunity.

The 3 Best Digital Health Stocks for Personalized Medicine

Digital health stocks are becoming increasingly relelvant as more and more people seek greater control over their health.

Alex Sirois on InvestorPlace | November 25, 2023

Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference

EL MONTE, Calif., November 14, 2023--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.

Yahoo | November 14, 2023

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call […]

Yahoo | November 5, 2023

Q3 2023 Fulgent Genetics Inc Earnings Call

Q3 2023 Fulgent Genetics Inc Earnings Call

Yahoo | November 4, 2023

Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting

EL MONTE, Calif., November 03, 2023--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced data from two poster presentations being presented tomorrow, November 4, 2023, at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting in San Diego, CA.

Yahoo | November 3, 2023

Read More 'FLGT' Stories Here

FLGT Price Returns

1-mo 5.06%
3-mo -8.00%
6-mo -22.17%
1-year -46.24%
3-year N/A
5-year 259.93%
YTD -26.05%
2023 -2.92%
2022 -70.39%
2021 93.07%
2020 303.88%
2019 306.94%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!